uniQure NV

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: NL0010696654
USD
15.92
-0.17 (-1.06%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
bluebird bio, Inc.
MaxCyte, Inc.
uniQure NV
Precigen, Inc.
Voyager Therapeutics, Inc.
Terns Pharmaceuticals, Inc.
Edgewise Therapeutics, Inc.
Lyell Immunopharma, Inc.
Aura Biosciences, Inc.
Aldeyra Therapeutics, Inc.
Renovaro, Inc.

Why is uniQure NV ?

1
Negative results in Sep 25
  • NET SALES(HY) At USD 8.96 MM has Grown at -33.18%
  • PRE-TAX PROFIT(Q) At USD -70.08 MM has Fallen at -72.04%
  • INVENTORY TURNOVER RATIO(HY) Lowest at 0 times
2
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 16.20%, its profits have fallen by -1.2%
3
Reducing Promoter Confidence
  • Promoters have decreased their stake in the company by -1.47% over the previous quarter and currently hold 5.1% of the company
  • Promoters decreasing their stake may signify reduced confidence in the future of the business
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is uniQure NV for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
uniQure NV
16.2%
0.70
278.02%
S&P 500
16.12%
0.84
19.28%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
21.09%
EBIT Growth (5y)
-6.51%
EBIT to Interest (avg)
-1.19
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
2.76
Sales to Capital Employed (avg)
0.06
Tax Ratio
1.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
42.66%
ROE (avg)
11.19%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.29
EV to EBIT
-4.19
EV to EBITDA
-4.57
EV to Capital Employed
14.50
EV to Sales
51.36
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-345.96%
ROE (Latest)
-104.93%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company
NET PROFIT(HY)

Higher at USD -114.17 MM

NET SALES(Q)

At USD 3.7 MM has Grown at 61.83%

RAW MATERIAL COST(Y)

Fallen by -87.02% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at -71.08 %

-17What is not working for the Company
NET SALES(HY)

At USD 8.96 MM has Grown at -33.18%

PRE-TAX PROFIT(Q)

At USD -70.08 MM has Fallen at -72.04%

INVENTORY TURNOVER RATIO(HY)

Lowest at 0 times

INTEREST(Q)

Highest at USD 16.72 MM

NET PROFIT(Q)

Lowest at USD -78.71 MM

Here's what is working for uniQure NV

Net Sales
At USD 3.7 MM has Grown at 61.83%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very positive

Net Sales (USD MM)

Debt-Equity Ratio
Lowest at -71.08 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost
Fallen by -87.02% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for uniQure NV

Pre-Tax Profit
At USD -70.08 MM has Fallen at -72.04%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD -78.71 MM has Fallen at -93.36%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Interest
Highest at USD 16.72 MM
in the last five periods and Increased by 7.25% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Net Profit
Lowest at USD -78.71 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (USD MM)

Inventory Turnover Ratio
Lowest at 0 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio